Lars Damstrup

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

Robert J. Coffey, C J Hawkey, Lars Damstrup et al. · Proceedings of the National Academy of Sciences · 1997 · 316 citations

Life Sciences, Cell Biology, Oncology +16

Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.

J. A. Barnard, Ramona Graves‐Deal, Mark R. Pittelkow et al. · Journal of Biological Chemistry · 1994 · 191 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

Mark T. J. van Bussel, Ahmad Awada, Maja J.A. de Jonge et al. · British Journal of Cancer · 2020 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

Alison M. Schram, Leena Gandhi, Monica Mita et al. · British Journal of Cancer · 2018 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies

Jens Benn Sørensen, Torben Skovsgaard, E Bork et al. · Cancer · 2008 · 85 citations · Full text

Pharmacy, Oncology, Pharmacology +17